Hydrophilic interaction LC-MS/MS analysis of opioids in urine: Significance of glucuronide metabolites

Bioanalysis

Volumn 3, Issue 23, 2011, Pages 2603-2612

  French, Deborah ^a   Wu, Alan ^a,b   Lynch, Kara ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; CODEINE 6 BETA DEXTRO GLUCURONIDE; DRUG METABOLITE; HYDROCODONE; HYDROMORPHONE; HYDROMORPHONE 6 BETA DEXTRO GLUCURONIDE; MORPHINE; MORPHINE 6 GLUCURONIDE; NARCOTIC ANALGESIC AGENT; OXYCODONE; OXYMORPHONE; OXYMORPHONE 6 BETA DEXTRO GLUCURONIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; DRUG URINE LEVEL; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; PROCESS DEVELOPMENT; TANDEM MASS SPECTROMETRY; URINALYSIS;

ANALGESICS, OPIOID; CHROMATOGRAPHY, LIQUID; CODEINE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCURONIDES; HUMANS; HYDROCODONE; HYDROMORPHONE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; OXYCODONE; OXYMORPHONE; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 82955205886     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.266     Document Type: Article

References (32)

1. Milne RW, Nation RL, Somogyi AA. The disposition of morphine and its 3-and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab. Rev. 28(3), 345-472 (1996). (Pubitemid 26300413)
2. Coffman BL, Rios GR, King CD, Tephly TR. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab. Disp. 25(1), 1-4 (1997). (Pubitemid 27045126)
3. Mannering GJ, Dixon AC, Baker EM, Asami T. The in vivo liberation of morphine from codeine in man. J. Pharmacol. Exp. Ther. 111(2), 142-146 (1954).
4. Nomof H, Elliott H W, Parker KD. Actions and metabolism of codeine (methylmorphine) administration by continuous intravenous infusion to humans. Clin. Toxicol. 11, 517-529 (1977). (Pubitemid 8305643)
5. Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6-beta-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251(2), 477-483 (1989). (Pubitemid 20005587)
6. Srinivasan V, Wielbo D, Simpkins J et al. Analgesic and immunomodulatory effects of codeine and codeine-6-glucuronide. Pharm. Res. 13(2), 296-300 (1996). (Pubitemid 26072151)
7. Coffman BL, King CD, Rios GR, Tephly TR. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab. Dispos. 26(1), 73-77 (1998). (Pubitemid 28071328)
8. Bhasker CR, McKinnon W, Stone A et al. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical signifcance. Pharmacogenetics 10(8), 679-685 (2000).
9. Saito K, Moriya H, Sawaguchi T et al. Haplotype analysis of UDP-glucuronosyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects. Clin. Biochem. 39(3), 303-308 (2006).
10. Zanger UM, Raimundo S, Eichelbaum M. Cytochrome P450 2D6: overview and update on pharmacology, genetics and biochemistry. Naunyn Schmiedebergs Arch. Pharmacol. 369, 23-37 (2004). (Pubitemid 38161221)
11. Cone EJ, Heit HA, Yale HC, Gourlay D. Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine. J. Anal. Toxicol. 30(1), 1-6 (2006).
12. Oyler JM, Cone EJ, Hoseph RE Jr, Huestis MA. Identifcation of hydrocodone in human urine following controlled codeine administration. J. Anal. Toxicol. 24(7), 530-535 (2000).
13. Baselt RC, Stewart CB. Determination of oxycodone and a major metabolite in urine by electron-capture GLC. J. Anal. Toxicol. 2(3), 107-109 (1978). (Pubitemid 8384715)
14. Shakleya DM, Dams R, Choo RE, Jones H. Huestis MA. Simultaneous liquid chromatography-MS quantifcation of urinary opiates, cocaine and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment. J. Anal. Toxicol. 34, 17-25 (2010).
15. Coles R, Kushnir MM, Nelson GJ, McMillin GW, Urry FM. Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone and 6-acetylmorphine in urine, serum, plasma, whole blood and meconium by LC-MS/MS. J. Anal. Toxicol. 31, 1-14 (2007).
16. Berg T, Lundanes E, Christophersen AS, Strand DH. Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC-MS/MS. J. Chromatog B 877, 421-432 (2009).
17. Svensson JO, Andersson M, Gustavsson E, Beck O. Electrospray LC-MS method with solid-phase extraction for accurate determination of morphine-, codeine-and ethylmorphine-glucuronides and 6-acetylmorphine in urine. J. Anal. Toxicol. 31, 81-86 (2007). (Pubitemid 46557478)
18. Dams R, Murphy CM, Lambert WE, Huestis MA. Urine drug testing for opioids, cocaine and metabolites by direct injection liquid chromatography- tandem MS. Rapid Commun. Mass Spectrom. 17, 1665-1670 (2003). (Pubitemid 36841349)
19. de Jager AD, Bailey NL. Online extraction LC-MS/MS method for the simultaneous quantitative confrmation of urine drugs of abuse and metabolites: amphetamines, opiates, cocaine, cannabis, benzodiazepines and methadone. J. Chromatog. B 879, 2642-2652 (2011).
20. Murphy CM, Huestis MA. LC-ESI-MS/MS analysis for the quantifcation of morphine, codeine, morphine-3-p-D-glucuronide, morphine-6-p-D-glucuronide and codeine-6-p-D-glucuronide in human urine. J. Mass Spectrom. 40, 1412-1416 (2005).
21. Wang P, Stone JA, Chen KH et al. Incomplete recovery of prescription opioids in urine using enzymatic hydrolysis of glucuronide metabolites. J. Anal. Toxicol. 30, 570-575 (2006). (Pubitemid 44600848)
22. Meatherall R. GC-MS confrmation of codeine, morphine 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone and oxymorphone in urine. J. Anal. Toxicol. 23(3), 177-186 (1999).
23. Jennison TA, Wozniak E, Nelson G, Urry FM. The quantitative conversion of morphine-3-b-D-glucuronide to morphine using beta-glucuronidase obtained from Patella vulgata as compared to acid hydrolysis. J. Anal. Toxicol. 17(4), 208-210 (1993). (Pubitemid 23212199)
24. Cremese M, Wu AHB, Cassella G et al. Improved GC-MS analysis of opiates with use of oxime-TMS derivatives. J. Forensic Sci. 43(6)1220-1224 (1998). (Pubitemid 28554822)
25. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75, 3019-3030 (2003). (Pubitemid 36830428)
26. Antonilli L, Semeraro F, Suriano C, Signore L, Nencini P. High levels of morphone-6-glucuronide in street heroin addicts. Psychopharmacol. 170, 200-204 (2003). (Pubitemid 37421531)
27. Baselt, RC. Disposition of Toxic Drugs and Chemicals in Man. (7th Edition). Biomedical Publications, Foster City, CA, USA2004.
28. Rook EJ, Huitema ADR, van den Brink W, van Ree JM, Beijnen JH. Population pharmacokinetics of heroin and its major metabolites. Clin. Pharmacokinet. 45, 401-417 (2006).
29. Bogusz MJ, Maier R-D, Erkens M, Driessen S. Determination of morphine and its 3-and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fuids by liquid chromatography atmospheric pressure chemical ionization MS. J. Chromatog. B 703, 115-127 (1997). (Pubitemid 28011250)
30. Hara Y, Nakajima M, Miyamoto K, Yokoi T. Morphine glucuronosyltransferase activity in human liver microsomes is inhibited by a variety of drugs that are co-administered with morphine. Drug Metab. Pharmacokinet. 22, 103-112 (2007).
31. Nieminen TH, Hagelberg NM, Saari TI et al. Grapefruit juice enhances the exposure to oral oxycodone. Basic Clin. Pharmacol. Toxicol. 107, 782-788 (2010).
32. Kimura Y, Ito H, Ohnishi R, Hatano T. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem. Toxicol. 48, 429-435 (2010).